<DOC>
	<DOCNO>NCT00214279</DOCNO>
	<brief_summary>Part 1 study gradually withdraw steroid group 50 old renal transplant recipient , convert 3 drug regimen 2 drug regimen ( cyclosporine MMF ) , carefully monitor graft function . 25 subject would serve control patient study would remain 3 drug regimen ( steroid , cyclosporine MMF ) . Immunologic status determine IS withdrawal use delayed-type hypersensitivity ( DTH ) transfer test previously describe original submission . Both steroid withdrawal subject control subject undergo DTH test throughout 3 year study participation .</brief_summary>
	<brief_title>MMF Monotherapy Immune Regulation Kidney Transplant Recipients : Part 1 Steroid Withdrawal</brief_title>
	<detailed_description />
	<mesh_term>Prednisone</mesh_term>
	<criteria>Patient receive kidney transplant `` MMF era '' Patients stable graft function indicate serum creatinine &lt; 1.8 mg/dl , calculate creatinine clearance &gt; 50 ml/minute Patients &gt; 1 rejection episode , Patients rejection episode within past year ; Patients steroid dependent due preexist disease ( example , RA SLE</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>